Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
复制标题
DOI:
10.3389/fimmu.2021.670561
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Tomaras GD
中科院分区:
文献类型:
--
作者:
Nyanhete TE;Edwards RJ;LaBranche CC;Mansouri K;Eaton A;Dennison SM;Saunders KO;Goodman D;Janowska K;Spreng RL;Zhang L;Mudrak SV;Hope TJ;Hora B;Bradley T;Georgiev IS;Montefiori DC;Acharya P;Tomaras GD
Broadly neutralizing antibodies (bNAbs), known to mediate immune control of HIV-1 infection, only develop in a small subset of HIV-1 infected individuals. Despite being traditionally associated with patients with high viral loads, bNAbs have also been observed in therapy naïve HIV-1+ patients naturally controlling virus replication [Virus Controllers (VCs)]. Thus, dissecting the bNAb response in VCs will provide key information about what constitutes an effective humoral response to natural HIV-1 infection. In this study, we identified a polyclonal bNAb response to natural HIV-1 infection targeting CD4 binding site (CD4bs), V3-glycan, gp120-gp41 interface and membrane-proximal external region (MPER) epitopes on the HIV-1 envelope (Env). The polyclonal antiviral antibody (Ab) response also included antibody-dependent cellular phagocytosis of clade AE, B and C viruses, consistent with both the Fv and Fc domain contributing to function. Sequence analysis of envs from one of the VCs revealed features consistent with potential immune pressure and virus escape from V3-glycan targeting bNAbs. Epitope mapping of the polyclonal bNAb response in VCs with bNAb activity highlighted the presence of gp120-gp41 interface and CD4bs antibody classes with similar binding profiles to known potent bNAbs. Thus, these findings reveal the induction of a broad and polyfunctional humoral response in VCs in response to natural HIV-1 infection.
登录
查看更多内容
影响因子:
5.4
作者:
Anthony C;York T;Bekker V;Matten D;Selhorst P;Ferreria RC;Garrett NJ;Karim SSA;Morris L;Wood NT;Moore PL;Williamson C
通讯作者:
Williamson C
影响因子:
64.8
作者:
Caskey M;Klein F;Lorenzi JC;Seaman MS;West AP Jr;Buckley N;Kremer G;Nogueira L;Braunschweig M;Scheid JF;Horwitz JA;Shimeliovich I;Ben-Avraham S;Witmer-Pack M;Platten M;Lehmann C;Burke LA;Hawthorne T;Gorelick RJ;Walker BD;Keler T;Gulick RM;Fätkenheuer G;Schlesinger SJ;Nussenzweig MC
通讯作者:
Nussenzweig MC
影响因子:
7.3
作者:
Hutchinson,Jennie M.;Mesa,Kathryn A.;Berman,Phillip W.
通讯作者:
Berman,Phillip W.
影响因子:
64.5
作者:
Bonsignori M;Zhou T;Sheng Z;Chen L;Gao F;Joyce MG;Ozorowski G;Chuang GY;Schramm CA;Wiehe K;Alam SM;Bradley T;Gladden MA;Hwang KK;Iyengar S;Kumar A;Lu X;Luo K;Mangiapani MC;Parks RJ;Song H;Acharya P;Bailer RT;Cao A;Druz A;Georgiev IS;Kwon YD;Louder MK;Zhang B;Zheng A;Hill BJ;Kong R;Soto C;NISC Comparative Sequencing Program;Mullikin JC;Douek DC;Montefiori DC;Moody MA;Shaw GM;Hahn BH;Kelsoe G;Hraber PT;Korber BT;Boyd SD;Fire AZ;Kepler TB;Shapiro L;Ward AB;Mascola JR;Liao HX;Kwong PD;Haynes BF
通讯作者:
Haynes BF
DOI:
10.1086/654816
发表时间:
2010-08-15
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Gilbert P;Wang M;Wrin T;Petropoulos C;Gurwith M;Sinangil F;D'Souza P;Rodriguez-Chavez IR;DeCamp A;Giganti M;Berman PW;Self SG;Montefiori DC
通讯作者:
Montefiori DC